
Sign up to save your podcasts
Or


In this episode, we take a deep dive into the state of the treatment pipeline for bleeding disorders. From the way clinical trials are structured to what’s actually available for different conditions, we examine both the promise and the reality of innovation in this space. Recorded live at the NBDF Bleeding Disorders Conference, we join Mike Recht, MD, PhD, Chief Science and Medical Officer of NBDF, for a “research posters walk & talk” to explore what’s happening right now — and why so many promising treatments never make it to market.
Guests:
Mike Recht, MD, PhD
Maria Santaella, PhD(c), MSN, RN-BC, CPHON
Samantha Carlson, LMSW
Senior Advisor: Donna DiMichele, MD
Hosted by: Patrick James Lynch
Written by: Kay Vermeil
Featured Advertiser:
Sanofi
Subscribe to the Global Hemophilia Report
Show Notes:
Join Kevin as he shares about his journey with hemophilia and the hurdles he faced in communicating with friends, family, and healthcare providers about his condition. He highlights how hemophilia affects far more than just physical health — and why honest, open conversations that focus on the full patient experience, not just symptoms, are so essential.
Click here to watch his story: https://www.youtube.com/watch?v=3v1cCTbhClA&list=PLmqBxf22n4lNK82h3QZ-9YlpIjYdzDOer&index=5
Sanofi’s Global Hemophilia Survey uncovers significant care gaps and emotional challenges faced by patients and caregivers. Learn how improving health literacy and fostering better patient-provider communication are essential to addressing these inequities. Explore the findings and see how Sanofi is driving health equity for the hemophilia community. Explore the survey findings here: Global Hemophilia Survey Page.
Connect with the Global Hemophilia Report
Global Hemophilia Report on LinkedIn
Global Hemophilia Report on X/Twitter
Global Hemophilia Report on Facebook
Connect with BloodStream Media:
BloodStreamMedia.com
BloodStream on Facebook
BloodStream on X/Twitter
By BloodStream Media5
1010 ratings
In this episode, we take a deep dive into the state of the treatment pipeline for bleeding disorders. From the way clinical trials are structured to what’s actually available for different conditions, we examine both the promise and the reality of innovation in this space. Recorded live at the NBDF Bleeding Disorders Conference, we join Mike Recht, MD, PhD, Chief Science and Medical Officer of NBDF, for a “research posters walk & talk” to explore what’s happening right now — and why so many promising treatments never make it to market.
Guests:
Mike Recht, MD, PhD
Maria Santaella, PhD(c), MSN, RN-BC, CPHON
Samantha Carlson, LMSW
Senior Advisor: Donna DiMichele, MD
Hosted by: Patrick James Lynch
Written by: Kay Vermeil
Featured Advertiser:
Sanofi
Subscribe to the Global Hemophilia Report
Show Notes:
Join Kevin as he shares about his journey with hemophilia and the hurdles he faced in communicating with friends, family, and healthcare providers about his condition. He highlights how hemophilia affects far more than just physical health — and why honest, open conversations that focus on the full patient experience, not just symptoms, are so essential.
Click here to watch his story: https://www.youtube.com/watch?v=3v1cCTbhClA&list=PLmqBxf22n4lNK82h3QZ-9YlpIjYdzDOer&index=5
Sanofi’s Global Hemophilia Survey uncovers significant care gaps and emotional challenges faced by patients and caregivers. Learn how improving health literacy and fostering better patient-provider communication are essential to addressing these inequities. Explore the findings and see how Sanofi is driving health equity for the hemophilia community. Explore the survey findings here: Global Hemophilia Survey Page.
Connect with the Global Hemophilia Report
Global Hemophilia Report on LinkedIn
Global Hemophilia Report on X/Twitter
Global Hemophilia Report on Facebook
Connect with BloodStream Media:
BloodStreamMedia.com
BloodStream on Facebook
BloodStream on X/Twitter

43 Listeners

112,351 Listeners

14 Listeners

24 Listeners

42 Listeners

6 Listeners

8,198 Listeners

9 Listeners

15 Listeners

2 Listeners

12 Listeners

10 Listeners